[1] |
Sood G, Siddik AB. Ocular ischemic syndrome[M]. Treasure Island: StatPearls Publishing, 2022.
|
[2] |
Hedges TR. Ophthalmoscopic findings in internal carotid artery occlusion[J]. Am J Ophthalmol, 1963, 55: 1007-1012.
|
[3] |
Hung JH, Chang YS. Ocular ischemic syndrome[J]. CMAJ, 2017, 189(23): e804.
|
[4] |
Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55: 2-34.
|
[5] |
Hayreh SS. Acute retinal arterial occlusive disorders[J]. Prog Retin Eye Res, 2011, 30(5): 359-394.
|
[6] |
Luo J, Yan Z, Jia Y, et al. Clinical analysis of 42 cases of ocular ischemic syndrome[J]. J Ophthalmol, 2018, PMID: 29713523.
|
[7] |
Kim YH, Sung MS, Park SW. Clinical features of ocular ischemic syndrome and risk factors for neovascular glaucoma[J]. Korean J Ophthalmol, 2017, 31: 343-350.
|
[8] |
Chen CS, Varma D, Lee A. Arterial occlusions to the eye: from retinal emboli to ocular ischemic syndrome[J]. Asia Pac J Ophthalmol (Phila), 2020, 9(4): 349-357.
|
[9] |
Bird B, Stawicki SP. Anatomy, head and neck, ophthalmic arteries[M]. Treasure Island: StatPearls Publishing LLC, 2021.
|
[10] |
Lawrence PF, Oderich GS. Ophthalmologic findings as predictors of carotid artery disease[J]. Vasc Endovascular Surg, 2002, 36: 415-424.
|
[11] |
Barbara TB, Skonieczna K, Iwona GL. Ocular ischemic syndrome: a systematic review[J]. Med Sci Monit, 2012, 18: RA138-RA144.
|
[12] |
Sivalingam A, Brown GC, Magargal LE, et al. The ocular ischemic syndrome (Ⅱ): Mortality and systemic morbidity[J]. Int Ophthalmol, 1989, 13(3): 187-191.
|
[13] |
Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55: 2-34.
|
[14] |
Wang H, Wang Y, Li H. Multimodality imaging assessment of ocular ischemic syndrome[J]. J Ophthalmol, 2017, PMID: 29375911.
|
[15] |
Brown GC, Magargal LE. The ocular ischemic syndrome.Clinical, fluo-rescein angiographic and carotid angiographic features[J]. Int Ophthalmol, 1988, 11(4): 239-251.
|
[16] |
Anguita R, Nazar C, Kobus R, et al. Bilateral ocular ischemic syndrome as a manifestation of Takayasu arteritis in children[J]. Can J Ophthalmol, 2019, 54(3): e105-e108.
|
[17] |
Vilares-Morgado R, Nunes HMM, Dos-Reis RS, et al. Management of ocular arterial ischemic diseases: a review[J]. Graefes Arch Clin Exp Ophthalmol, 2022, PMID: 35838806.
|
[18] |
Makhkamova DК. Etiopathogenesis of ocular ischemic syndrome[J]. Vestn Oftalmol, 2017, 133(2): 120-124.
|
[19] |
Gostimir M, Wehrli BJ, Fraser JA. Ocular ischemic syndrome secondary to inflammatory pseudotumor of the skull base masquerading as giant cell arteritisl[J]. J Neuroophthalmol, 2021, 41(3): e309-e311.
|
[20] |
Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome——a systematic review[J]. Med Sci Monit, 2012, 18(8): RA138-RA144.
|
[21] |
Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome[J]. Ophthalmology, 1997, 104(5): 859-864.
|
[22] |
Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses[J]. Retina, 2014, 34(1): 115-122.
|
[23] |
Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome[J]. Prog Retin Eye Res, 2014, 41: 1-25.
|
[24] |
Legocki AT, Davis JA, Francis CE.Anisocoria due to ocular ischemic syndrome[J].J Neuroophthalmol, 2022, PMID: 35421029.
|
[25] |
López-Herrero F, Montenegro-Quintana MA, Franco-Ruedas C, et al. Lens subluxation in two cases of ocular ischemic syndrome: A late complication[J]. J Fr Ophtalmol, 2022, 45(6): 664-666.
|
[26] |
Ma F, Su J, Shang Q, et al. Changes in Ocular hemodynamics after Carotid Artery Angioplasty and Stenting (CAAS) in patients with different severity of ocular ischemic syndrome[J].Curr Eye Res, 2018, 43(2): 266-272.
|
[27] |
Chen KJ, Chen SN, Kao LY, et al. Ocular ischemic syndrome[J]. Chang Gung Med J, 2001, 24(8): 483-491.
|
[28] |
Dumbräveanu L, Cuçnir V, Bobescu D. A review of neovascular glaucoma: Etiopathogenesis and treatment[J]. Rom J Ophthalmol, 2021, 65(4): 315-329.
|
[29] |
Utsugi N, Takahashi K, Kishi S. Choroidal vascular occlusion in internal carotid artery obstruction[J]. Retina, 2004, 24(6): 915-919.
|
[30] |
Dae HK, Yu CK, Kyung TK. Clinical significance of choroidal thickness in eyes with ocular ischemic syndrome[J]. Korean J Ophthalmol, 2022, 36(1): 66-73.
|
[31] |
Tuĝba KĪ,Derya T, Göksu Hᶊ,et al. Optical cohorence tomography angiography findings in carotid artery stenosis[J]. Int Ophthalmol, 2022, 42(8): 2501-2509.
|
[32] |
Story JL, Held KS, Harrison JM, et al. The ocular ischemic syndrome in carotid artery occlusive disease: ophthalmic color Doppler flow velocity and electroretinographic changes following carotid artery reconstruction[J]. Surg Neurol, 1995, 44(6): 534-535.
|
[33] |
Hong IH, Ahn JK, Chang S, et al. Diagnostic efficacy of total homocysteine and C-reactive protein for ocular ischemic syndrome[J]. Eye (Lond), 2011, 25(12): 1650-1654.
|
[34] |
Cãlugãru D, Cãlugãru M. Etiology, pathogenesis, and diagnosis of neovascular glaucoma[J]. Int J Ophthalmol, 2022, 15(6): 1005-1010.
|
[35] |
Hassaan A, Si ZJ, Steven Q, et al. Neovascular glaucoma from ocular ischemic syndrome treated with serial monthly intravitreal bevacizumab and panretinal photocoagulation: a case report[J]. Case Rep Ophthalmol Med, 2022, PMID: 35935916.
|
[36] |
Malhotra R, Gregory-Evans K. Management of ocular ischaemic syndrome[J]. Br J Ophthalmol, 2000, PMID: 11090489.
|
[37] |
Van-Keer K, Breda JB, Pinto LA, et al. Estimating mean ocular perfusion pressure using mean arterial pressure and intraocular pressure[J]. Invest Ophthalmol Vis Sci, 2016, 57(4): 2260.
|
[38] |
Deboer C, Wong BJ, Ameri H. Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma: a retrospective study[J]. 2022, 27(1): 24.
|
[39] |
Choi EY, Lee SC, Kim M. Optical coherence tomography angiography before and after bevacizumab injection in ocular ischemic syndrome[J]. Retina, 2018, 38(3): e23-e25.
|
[40] |
Kofoed PK, Munch IC, Larsen M. Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome[J]. Acta Ophthalmol, 2010, 88(7): 808-810.
|
[41] |
Lee D, Tomita Y, Miwa Y, et al. Fenofibrate protects against retinal dysfunction in a murine model of common carotid artery occlusion-induced ocular ischemia[J]. Pharmaceuticals, 2021, 14: 223.
|
[42] |
Paul TC, Yean TL, Cheng KO, et al. Severe carotid stenosis presenting as ipsilateral ocular ischaemic syndrome: successful treatment with carotid artery stenting[J]. Singapore Med J, 2021, 62(12): 667-669.
|
[43] |
Metry Y, Joseph S. Optic disc neovascularization as the only sign of ocular ischemic syndrome: a case report [J]. Cureus, 2022, 14(10): e29972.
|
[44] |
Saito K, Akiyama H, Mukai R. Alteration of optical coherence tomography angiography in a patient with ocular ischemic syndrome[J]. Retin Cases Brief Rep, 2021, 15(5): 588-592.
|
[45] |
Eckstein HH. European society for vascular surgery guide-lines on the management of atherosclerotic carotid and vertebral artery disease[J]. Eur J Vasc Endovasc Surg, 2018, 55(1): 1-2.
|
[46] |
Cheng SF, Zarkali A, Richards T, et al. Carotid artery stenosis, an underestimated cause of stroke recurrence in patients with ischaemic monocular visual loss[J]. Ann R Coll Surg Engl, 2019, 101(8): 579-583.
|
[47] |
Lichtman JH, Jones MR, Leifheit EC, et al. Carotid end-arterectomy and carotid artery stenting in the US Medicare population, 1999—2014[J]. JAMA, 2017, 318(11): 1035-1046.
|
[48] |
Farrell B, Fraser A, Sandercock P, et al. Randomised trial of endarterectomy for recently sympto-matic carotid stenosis: nal results of the MRC European Carotid Surgery Trial (ECST)[J]. Lancet, 1998, 351(9113): 1379-1387.
|
[49] |
Lauria AL, Koelling EE, Houghtaling PM, et al. Carotid endarterectomy for ocular ischemic syndrome: a case report and review of the literature[J]. Ann Vasc Surg, 2020, 67: e9-e12.
|
[50] |
Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery[J]. Lancet, 2004, 363(9413): 915-924.
|
[51] |
Tsivgoulis G, Krogias C, Georgiadis GS, et al. Safety of early endarterectomy in patients with symptomatic carotid artery stenosis: an international multi-center study[J]. Eur J Neurol, 2014, 21(10): e75-e76.
|
[52] |
Faateh M, Dakour-Aridi H, Kuo PL, et al. Risk of emergent carotid endarterectomy varies by type of presenting symptoms[J]. J Vasc Surg, 2019, 70(1): 130-137.
|
[53] |
Sadri BS, Low DW, Jackson OA, et al. Subclavian to carotid artery bypass for a case of ocular ischemic syndrome[J]. Vascular, 2023, PMID: 36917226.
|